Relevance of Fusion Genes in Pediatric Cancers: Toward Precision Medicine
Pediatric cancers differ from adult tumors, especially by their very low mutational rate. Therefore, their etiology could be explained in part by other oncogenic mechanisms such as chromosomal rearrangements, supporting the possible implication of fusion genes in the development of pediatric cancers...
Saved in:
Main Authors: | Célia Dupain (Author), Anne Catherine Harttrampf (Author), Giorgia Urbinati (Author), Birgit Geoerger (Author), Liliane Massaad-Massade (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Knocking Down TMPRSS2-ERG Fusion Oncogene by siRNA Could be an Alternative Treatment to Flutamide
by: Giorgia Urbinati, et al.
Published: (2016) -
Pediatrics in the era of precision medicine and precision epidemiology
by: Janne Estill
Published: (2023) -
Parental Attitudes toward Artificial Intelligence-Driven Precision Medicine Technologies in Pediatric Healthcare
by: Bryan A. Sisk, et al.
Published: (2020) -
Predicting Therapeutic Response in Pediatric Ulcerative Colitis-A Journey Towards Precision Medicine
by: Ruben J. Colman, et al.
Published: (2021) -
Pharmacometabolomics informs viromics towards precision medicine
by: Aggeliki Balasopoulou, et al.
Published: (2016)